What is the significance of an elevated gamma‑glutamyl transferase (GGT) of 144 U/L with normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, and what are the recommended next steps in evaluation?

Elevated GGT with Normal Transaminases: Cholestatic Pattern Requiring Alcohol Assessment and Imaging

Your liver enzyme pattern shows an isolated elevation of GGT (144 U/L) with normal ALT and AST, indicating a cholestatic process that requires alcohol history assessment, metabolic risk factor evaluation, and abdominal ultrasound as the initial imaging study.

Understanding Your Pattern

This is a cholestatic-predominant pattern rather than hepatocellular injury. The elevated GGT with normal aminotransferases (ALT 38, AST 26) confirms the GGT elevation is of hepatic origin and indicates cholestasis 1. GGT helps confirm that elevated alkaline phosphatase originates from the liver rather than bone, though your ALP wasn't mentioned 1.

Most Common Causes to Evaluate

Alcohol-Related Liver Disease (Priority #1)

• GGT >100 U/L is a critical threshold that warrants fibrosis assessment according to guidelines 2
• Your GGT of 144 U/L exceeds this threshold
• Complete an AUDIT questionnaire to assess alcohol consumption 2
• If drinking ≥35 units/week (women) or ≥50 units/week (men), you need Fibroscan/ARFI elastography for fibrosis risk stratification 2
• Even below these thresholds, GGT >100 U/L suggests consideration for fibrosis assessment 2

Metabolic Fatty Liver Disease (NAFLD)

• Assess for risk factors: BMI >25, type 2 diabetes, dyslipidemia, hypertension 2
• NAFLD prevalence reaches 70% with obesity and 90% with diabetes 1
• The AST:ALT ratio <1 (your ratio is 0.68) is more consistent with metabolic disease than alcohol-induced disease 1

Other Cholestatic Causes

• Medications/drugs causing cholestasis 1
• Chronic cholestatic processes: primary biliary cholangitis, primary sclerosing cholangitis 1
• Biliary obstruction (though less likely with normal transaminases)
• Infiltrative diseases: sarcoidosis, amyloidosis 1

Recommended Evaluation Algorithm

Step 1: Clinical Assessment

• Alcohol history using AUDIT questionnaire 2
• Medication review for hepatotoxic drugs 3
• Assess metabolic risk factors (diabetes, obesity, metabolic syndrome) 2
• Review for symptoms of biliary obstruction

Step 2: Initial Imaging

Ultrasound abdomen is the first-line study 1:

• Detects hepatic steatosis (>33% fat content with 84.8% sensitivity, 93.6% specificity) 1
• Evaluates biliary tree for obstruction 1
• Assesses for structural liver disease
• Non-invasive, widely available, and appropriate for this presentation 1

Step 3: Extended Laboratory Workup

If initial evaluation is unrevealing:

• Hepatitis B and C serologies
• Autoimmune markers (ANA, ASMA, immunoglobulins)
• Iron studies (ferritin, transferrin saturation)
• Consider alpha-1 antitrypsin level 4

Step 4: Fibrosis Risk Stratification

If GGT remains >100 U/L or alcohol/NAFLD risk factors present 2:

• Calculate FIB-4 or NAFLD Fibrosis Score
• Consider Fibroscan/ARFI elastography
• Refer to hepatology if Fibroscan >16 kPa or evidence of advanced disease 2

Critical Pitfalls to Avoid

1. Don't dismiss isolated GGT elevation as benign - it can represent early cholestatic disease or drug-induced liver injury even without meeting conventional DILI thresholds 3

2. Don't assume normal transaminases rule out significant liver disease - advanced fibrosis and cirrhosis can exist with normal ALT/AST 2

3. Don't overlook alcohol assessment - your GGT level specifically triggers the need for structured alcohol evaluation and potential fibrosis screening 2

4. Don't skip imaging - ultrasound is essential to exclude structural causes and detect steatosis 1

When to Refer to Hepatology

Refer if 2:

• Fibroscan >16 kPa
• Persistently elevated GGT despite negative workup and no NAFLD risk factors
• Evidence of cirrhosis or portal hypertension
• AUDIT score >19 (indicating alcohol dependency requiring specialized services) 2

The combination of your specific GGT level (>100 U/L) and the cholestatic pattern makes alcohol assessment and metabolic risk factor evaluation your immediate priorities, followed by ultrasound imaging 2, 1.